Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

Share Price is delayed by 15 minutes
Get Live Data
43.80    0.00 (0.00%)
Bid:
42.80
Ask:
44.80
Spread: 2.00 (4.673%)
Market Cap: £68.37m
MIG3 Live PriceLast checked at - London Stock Exchange

Intraday Maven Grwth 3 Share Chart

Dividend Declaration

6 Feb 2024 11:07

RNS Number : 1954C
Maven Income and Growth VCT 3 PLC
06 February 2024
 

 

Maven Income and Growth VCT 3 PLC

 

Proposed Final Dividend

 

On 18 December 2023, the Directors of Maven Income and Growth VCT 3 PLC ("the Company") announced that the unaudited net asset value of the Company as at 30 November 2023 was 52.48p per Ordinary Share.

 

The Directors propose that a final dividend of 2.15p per Ordinary Share, in respect of the year ended 30 November 2023, be paid on 3 May 2024 to Shareholders on the register at close of business on 22 March 2024.

 

As Shareholders will be aware from recent Annual and Interim Reports, decisions on distributions take into consideration a number of factors, including the availability of surplus revenue, the realisation of capital gains, the adequacy of distributable reserves and the VCT qualifying level. The Board and the Manager recognise the importance of tax-free distributions to Shareholders and, subject to the conditions set out above, will seek, as a guide, to pay an annual dividend that represents 5% of the NAV per share at the immediately preceding year end. This final dividend will bring total distributions for the financial year to 2.65p per Ordinary Share, representing an annual yield of 4.62%.

 

Since the Company's launch, and after receipt of this final dividend, a total of 99.72p per share will have been distributed in tax-free dividends. It should be noted that the effect of paying dividends is to reduce the NAV of the Company by the total cost of the distribution.

 

 

Dividend Investment Scheme

The Company has in place a Dividend Investment Scheme (DIS) through which Shareholders may elect to have their dividend payments used to apply for new Ordinary Shares issued by the Company under the standing authority requested from Shareholders at Annual General Meetings. Shares issued under the DIS should qualify for VCT tax reliefs applicable for the tax year in which they are allotted, subject to an individual Shareholder's particular circumstances. Terms & conditions of the scheme, together with a mandate form, are available from the Company's webpage at: mavencp.com/migvct3.

Shareholders who have not previously applied to participate in the DIS and who wish to do so in respect of the dividend payable on 3 May 2024, should ensure that a mandate form is received by the Company's Registrar, The City Partnership (UK) Limited, prior to the dividend election date of 12 April 2024. Election to participate in the DIS can also be made through the Registrar's online investor hub at: maven-cp.cityhub.uk.com.

 

Further to the information disclosed above, the Directors confirm that they are satisfied that all inside information (as defined by Article 7 of the Market Abuse Regulation (596/2014/EU)) that the Directors and the Company may have in their possession relating to the Company during the 30 day closed period leading up to the announcement of its annual results for the year ended 30 November 2023 has been or will be notified to a regulatory information service.

 

Issued on behalf of the Board

Maven Capital Partners UK LLP

Company Secretary

6 February 2024

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVEAFAKEELLEFA
Date   Source Headline
4th May 20102:43 pmRNSIssue of Equity
30th Apr 201011:09 amRNSAnnual Information Update
6th Apr 201011:19 amRNSIssue of Equity
1st Apr 20105:24 pmRNSIssue of Equity
8th Mar 20105:53 pmRNSAnnual Financial Report
26th Jan 201011:15 amRNSLinked Offer for Subscription
26th Jan 201011:15 amRNSLinked Offer for Subscription
26th Jan 201011:15 amRNSLinked Offer for Subscription
26th Jan 201011:15 amRNSLinked Offer for Subscription
5th Jan 201011:14 amRNSTotal Voting Rights
14th Dec 20099:59 amRNSChange of Name
7th Dec 200911:03 amRNSTransaction in Own Shares
26th Nov 200912:18 pmRNSResult of EGM
2nd Nov 20094:34 pmRNSChange of Adviser
30th Oct 20093:47 pmRNSNotice of EGM
16th Oct 200912:09 pmRNSInterim Management Statement
1st Sep 20099:39 amRNSTotal Voting Rights
3rd Aug 20093:53 pmRNSTransaction in Own Shares
27th Jul 20093:31 pmRNSCorrection to record date
24th Jul 20094:48 pmRNSHalf Yearly Report
10th Jun 200911:48 amRNSChange of Adviser
9th Apr 20093:55 pmRNSAGM Statement
9th Apr 20091:06 pmRNSInterim Management Statement
6th Apr 20092:57 pmRNSChange of Adviser
30th Mar 200911:05 amRNSAnnual Information Update
30th Mar 200910:15 amRNSAnnual Report and Accounts
10th Mar 200911:20 amRNSAnnual Report and Accounts
6th Mar 200910:26 amRNSC Ordinary shares (on conversion to Ordinary)
2nd Mar 200912:50 pmRNSConversion of Securities
17th Oct 20082:14 pmRNSInterim Management Statement
16th Oct 20082:54 pmRNSResult of EGM
29th Aug 200811:17 amRNSCirc re GM, and issue of inte
16th Jul 20084:34 pmRNSDirectorate Change
15th Jul 20084:17 pmRNSInterim Results
25th Apr 20083:24 pmRNSResult of AGM
17th Apr 200810:23 amRNSInterim Management Statement
7th Mar 20084:01 pmRNSAnnual Information Update
29th Feb 20084:23 pmRNSAnnual Report and Accounts
6th Feb 200811:51 amRNSFinal Results
20th Jul 20075:05 pmRNSInterim Results
12th Jun 20073:14 pmRNSAnnual Information Update
7th Jun 200712:47 pmRNSResult of AGM
7th Feb 20075:13 pmRNSFinal Results
20th Dec 20064:52 pmRNSTotal Voting Rights
8th Nov 20063:08 pmRNSNet Asset Value(s)
14th Jul 20065:11 pmRNSInterim Results
29th Jun 200610:51 amRNSDirector/PDMR Shareholding
29th Jun 200610:50 amRNSDirector/PDMR Shareholding
29th Jun 200610:40 amRNSDirector/PDMR Shareholding
24th May 20069:31 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.